Trial reportBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2026
[Treatment of peri-implant mucositis using an erythritol air-polishing or ultrasonic device: A randomized controlled trial].
Trial report in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the short-term clinical treatment effects of erythritol air-polishing(EAP) and ultrasonic debridement (US) on peri-implant mucositis and to report patient-reported outcomes.
methodsThis study is a single-blind, randomized controlled clinical trial. It enrolled patients diagnosed with peri-implant mucositis at the Department of Periodontology, Peking University School of Stomatology between June 2021 and May 2022. A total of 36 patients (with one implant included per patient) were randomly allocated to either the EAP group (
resultsBaseline clinical parameters were comparable between the EAP and US groups. Regarding the primary outcome of mean PPD, the EAP group showed a significant reduction from the baseline value (4.0±0.5) mm to (3.7±0.6) mm at 1 month and (3.4±0.5) mm at 3 months (
conclusionBoth EAP and US effectively treated peri-implant mucositis with comparable overall efficacy. However, EAP showed superior potential in reducing deep pockets over the short term, though this finding required further validation.
Indexed as
Identifiers
41633583PMC12872365What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.